Symptoms of SCC vary. They may include a persistent, scaly red patch, a firm, red nodule, a sore that does not heal, or a rough, scaly patch on the skin, lips, or inside the mouth. It is essential to underline that SCC can metastasize (spread) to other parts of the body if left untreated. According to the Skin Cancer Foundation, SCC is the second most common form of skin cancer, with an alarming estimate of about 1 million cases diagnosed in the United States each year.
Early diagnosis of SCC is crucial for successful treatment and improved prognosis. Dermatologists and other medical professionals play a pivotal role in diagnosing SCC through a comprehensive examination of the skin and evaluating any suspicious lesions or growths. If a potential SCC lesion is identified, a biopsy, where a small sample of tissue is removed and examined under a microscope, is performed to confirm the diagnosis.
In addition to biopsies, imaging tests such as CT scans, MRI scans, and PET scans may be utilized to determine the extent of the cancer and identify any potential metastasis. Laboratory tests, including blood tests and genetic testing, may also be conducted to assess the patient’s overall health and the specific characteristics of the cancer cells.
Timely and accurate diagnosis of SCC allows for the initiation of appropriate treatment and management strategies. Patients are encouraged to undergo regular skin examinations, especially if they have a history of excessive sun exposure or a family history of skin cancer.
The treatment of SCC is individualized based on the stage of the cancer, the location of the tumor, the overall health of the patient, and other relevant factors.
Surgery is often the preferred treatment for SCC, involving the removal of the cancerous growth and a surrounding margin of healthy tissue to ensure complete elimination of the tumor. Mohs micrographic surgery, a specialized technique that involves removing thin layers of cancerous skin and examining them under a microscope, is particularly effective for treating SCC in cosmetically and functionally critical areas.
Radiation therapy utilizes high-energy X-rays or other forms of radiation to kill cancer cells and shrink tumors. It may be recommended as the primary treatment for SCC in cases where surgery is not feasible or as an adjuvant therapy to eliminate any remaining cancer cells post-surgery.
Chemotherapy, either in the form of topical creams or systemic medications, may be prescribed for advanced or metastatic SCC. This treatment method involves the use of drugs to kill rapidly dividing cancer cells, though it may also affect healthy cells, leading to side effects such as nausea, hair loss, and fatigue.
Lastly, targeted therapy and immunotherapy are innovative approaches that specifically target and attack cancer cells while minimizing damage to healthy tissues. These treatments are designed to boost the body’s immune response against cancer cells and inhibit specific pathways or molecules involved in the growth and spread of SCC.
Surgery is often very effective for early-stage SCC, providing high cure rates while preserving the surrounding healthy tissue. However, it may not be suitable for extensive or metastatic cases. Radiation therapy is effective in controlling localized SCC and may be recommended as an alternative to surgery or in combination with surgery to reduce the risk of recurrence.
Chemotherapy, targeted therapy and immunotherapy however, are generally reserved for advanced, recurrent, or metastatic SCC, with the aim of slowing the progression of the disease and improving quality of life.
Several risk factors are associated with the development of SCC, primarily related to excessive sun exposure, tanning bed use, and other environmental factors. Individuals with fair skin, light-colored eyes, and a history of sunburns are at a higher risk of developing SCC, as their skin is more susceptible to UV damage. Additionally, chronic exposure to arsenic, coal tar, paraffin, and certain industrial chemicals may increase the likelihood of SCC.
Tobacco use, including smoking and smokeless tobacco, is also a significant risk factor for SCC, particularly in the development of oral and throat cancers. Furthermore, immunosuppression, as seen in individuals with human immunodeficiency virus (HIV), organ transplant recipients, and certain autoimmune disorders, can elevate the risk of SCC due to impaired immune surveillance and defense mechanisms.
Preventive measures and lifestyle changes play a crucial role in reducing the risk of SCC. Sun protection practices, such as wearing broad-brimmed hats and sunglasses, seeking shade, and using sunscreen with a high sun protection factor (SPF), are essential for minimizing UV exposure. Also, regular self-examinations of the skin and prompt evaluation of any new or changing lesions are recommended to facilitate early detection and intervention.
It is crucial for patients and their healthcare providers to weigh the potential benefits and risks of each treatment option and make informed decisions based on the specific characteristics of the cancer and the individual’s overall well-being.
Research and clinical trials continue to explore new and emerging treatment modalities for SCC, offering hope for improved outcomes and quality of life for affected individuals.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-advertisement | 1 year | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
elementor | never | No description available. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
_ga_FPHEVW83YC | 2 years | This cookie is installed by Google Analytics. |
Cookie | Duration | Description |
---|---|---|
_fbp | 3 months | This cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website. |
fr | 3 months | The cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin. |